STERIS plc
Steris
STE · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2026
- Revenue
- $5.9B
- Assets
- $10.7B
- SEC filing
- DEF 14A
- Filed
- June 11, 2026
Executive Compensation
Compensation reported for Steris’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Daniel A. Carestio
President and CEO
$11.5M
Reported total
- Salary
- $1,095,707
- Stock awards
- $4,333,951
- Incentives
- $1,725,007
- Option awards
- $4,334,251
- Other
- $19,606
Karen L. Burton
Senior Vice President And Chief Financial Officer
$3.2M
Reported total
- Salary
- $530,762
- Stock awards
- $1,042,037
- Incentives
- $491,493
- Option awards
- $1,111,148
- Other
- $16,977
J. Adam Zangerle
Senior Vice President, General Counsel, And Company Secretary
$3M
Reported total
- Salary
- $570,417
- Stock awards
- $913,947
- Incentives
- $538,815
- Option awards
- $914,376
- Other
- $16,910
Cary L. Majors
Senior Vice President And President, Healthcare
$2.5M
Reported total
- Salary
- $537,115
- Stock awards
- $711,010
- Incentives
- $473,535
- Option awards
- $711,242
- Other
- $17,522
Michael J. Tokich
Senior Financial Advisor
$2.2M
Reported total
- Salary
- $511,409
- Stock awards
- $540,923
- Incentives
- $616,644
- Option awards
- $541,234
- Other
- $19,783
Mary Clare Fraser
Senior Vice President And Chief Human Resources Officer
$2.1M
Reported total
- Salary
- $461,615
- Stock awards
- $609,542
- Incentives
- $377,902
- Option awards
- $609,401
- Other
- $15,262
Daniel A. Carestio
President and CEO
$11.5M
Reported total · FY2026 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed June 11, 2026.
- Salary
- $1.1M
- Stock Awards
- $4.3M
- Option Awards
- $4.3M
- Incentives
- $1.7M
- Other
- $20K
Historical Compensation
Daniel A. Carestio total compensation, fiscal years 2024–2026.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2026 | $1,095,707 | $4,333,951 | $11,508,522 |
| 2025 | $1,063,860 | $2,935,997 | $10,673,062 |
| 2024 | $1,030,600 | $2,584,412 | $9,550,776 |
Named Executive Officers
Daniel A. Carestio
President and CEO
Steris · STE
$11.5M
FY 2026 · DEF 14A
Karen L. Burton
Senior Vice President And Chief Financial Officer
Steris · STE
$3.2M
FY 2026 · DEF 14A
Michael J. Tokich
Senior Financial Advisor
Steris · STE
$2.2M
FY 2026 · DEF 14A
J. Adam Zangerle
Senior Vice President, General Counsel, And Company Secretary
Steris · STE
$3M
FY 2026 · DEF 14A
Cary L. Majors
Senior Vice President And President, Healthcare
Steris · STE
$2.5M
FY 2026 · DEF 14A
Mary Clare Fraser
Senior Vice President And Chief Human Resources Officer
Steris · STE
$2.1M
FY 2026 · DEF 14A
Source information
- Company
- STERIS plc
- Ticker
- STE · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2026
- Filing date
- June 11, 2026
- SEC accession number
- 0001193125-26-267599
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company